FLC
ZVSAW

Fifth Lane Capital’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Fifth Lane Capital’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-62,500
Closed -$8K – 237
2022
Q3 		$8K Buy
62,500
+25,000
+67% +$3.2K ﹤0.01% 112
2022
Q2 		$3K Hold
37,500
– – ﹤0.01% 312
2022
Q1 		$6K Buy
+37,500
New +$6K ﹤0.01% 296